• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

Introduction to 4-[(2-Piperidino-1,3-Thiazol-5-yl)methyl]Morpholine (CAS No. 478260-14-9)

4-[(2-Piperidino-1,3-thiazol-5-yl)methyl]morpholine (CAS No. 478260-14-9) is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This compound belongs to the class of heterocyclic amines, which are known for their diverse biological activities and roles in various physiological processes.

The molecular structure of 4-[(2-piperidino-1,3-thiazol-5-yl)methyl]morpholine consists of a morpholine ring linked to a thiazole ring through a methyl group, with a piperidine moiety attached to the thiazole ring. This intricate arrangement of functional groups imparts the compound with specific chemical and biological characteristics that make it an interesting candidate for further investigation.

Recent studies have highlighted the potential of 4-[(2-piperidino-1,3-thiazol-5-yl)methyl]morpholine in various therapeutic areas. One notable application is its use as a ligand for G protein-coupled receptors (GPCRs), which are key targets in drug discovery due to their involvement in numerous signaling pathways. Research has shown that this compound can modulate the activity of specific GPCRs, potentially leading to new treatments for conditions such as neurodegenerative diseases, inflammatory disorders, and metabolic syndromes.

In addition to its receptor modulation properties, 4-[(2-piperidino-1,3-thiazol-5-yl)methyl]morpholine has been explored for its antimicrobial and antiviral activities. Studies have demonstrated that this compound can inhibit the growth of certain bacteria and viruses, making it a promising candidate for developing new antimicrobial agents. The mechanism of action is thought to involve interference with essential microbial processes, such as cell wall synthesis or viral replication.

The pharmacokinetic profile of 4-[(2-piperidino-1,3-thiazol-5-yl)methyl]morpholine has also been investigated to assess its suitability for therapeutic use. Preliminary data suggest that the compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) properties. It is well-absorbed orally and has good bioavailability, which are important considerations for drug development.

From a safety perspective, 4-[(2-piperidino-1,3-thiazol-5-yl)methyl]morpholine has been evaluated in preclinical toxicity studies. These studies have indicated that the compound is generally well-tolerated at therapeutic doses, with no significant adverse effects observed. However, further research is needed to fully understand its long-term safety profile and potential side effects.

In conclusion, 4-[(2-piperidino-1,3-thiazol-5-yl)methyl]morpholine (CAS No. 478260-14-9) represents an intriguing molecule with a range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features and promising biological activities make it a valuable candidate for further investigation and development as a therapeutic agent. Ongoing research will likely uncover additional insights into its mechanisms of action and potential clinical uses.

• 1011-41-2(2-(morpholin-4-yl)-1,3-thiazole-5-carbaldehyde)
• 1341181-59-6(5-(Aminomethyl)-N-(2-methoxyethyl)-N-methylthiazol-2-amine)
• 921938-89-8([2-(morpholin-4-yl)-1,3-thiazol-5-yl]methanol)
• 893729-75-4(1-[2-(morpholin-4-yl)-1,3-thiazol-5-yl]methanamine)
• 3008-62-6(5-(Morpholin-4-ylMethyl)-1,3-thiazol-2-aMine)
• 2094339-52-1(N-[[2-(4-Morpholinyl)-5-thiazolyl]methyl]-2-propenamide)
• 2549014-35-7(4-(5-methyl-1,3-thiazol-2-yl)-2-(piperidine-1-carbonyl)morpholine)
• 2138016-52-9(1-{5-[(4-Amino-3-methylpiperidin-1-yl)methyl]-1,3-thiazol-2-yl}-3-(2-methoxyethyl)urea)
• 921938-91-2(methyl({2-(morpholin-4-yl)-1,3-thiazol-5-ylmethyl})amine)
• 439121-13-8(4-{5-[(4-Methylpiperazino)methyl]-1,3-thiazol-2-yl}morpholine)